Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.88313 | 37 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.83129 | 37 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.8275 | 36 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.81659 | 38 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.77309 | 36 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.90273 | 36 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.86464 | 36 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.81376 | 36 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.79364 | 36 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.81847 | 37 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.81873 | 36 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.80238 | 37 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.8249 | 36 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.82385 | 36 |